How big is Astria Therapeutics, Inc.?

Jun 22 2025 05:54 PM IST
share
Share Via
As of Jun 18, Astria Therapeutics, Inc. has a market capitalization of 321.68 million, with net sales of 0.00 million and a net profit of -108.04 million over the latest four quarters. Shareholder's funds are 319.26 million, and total assets amount to 342.36 million.
As of Jun 18, Astria Therapeutics, Inc. has a market capitalization of 321.68 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -108.04 million.

As of Dec 24, the reporting period shows Shareholder's Funds of 319.26 million and Total Assets of 342.36 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
What does Astria Therapeutics, Inc. do?
Jun 22 2025 06:33 PM IST
share
Share Via